Risk-Benefit Profile Still Favors Bisphosphonate for Fractures

(MedPage Today) -- The risk of atypical fractures increased with longer duration of bisphosphonate treatment, but the absolute risk remained low, a new study showed.
Looking at nearly 200,000 women ages 50 and older, Dennis Black, PhD, of the...